Electronic health record (EHR) based postmarketing surveillance of adverse events associated with pediatric off‐label medication use: A case study of short‐acting beta‐2 agonists and arrhythmias
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4562
Abstract: Use electronic health record (EHR) data to (1) estimate the risk of arrhythmia associated with inhaled short‐acting beta‐2 agonists (SABA) in pediatric patients and (2) determine whether risk varied by on‐label versus off‐label prescribing. read more here.
Keywords: acting beta; beta agonists; short acting; electronic health ... See more keywords
Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma.
Sign Up to like & getrecommendations! Published in 2020 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2020.41.200036
Abstract: BACKGROUND A step-up approach (increasing inhaled corticosteroid [ICS] dose and/or add-on treatment) is recommended for asthma that is uncontrolled despite ICS plus long-acting beta-2-agonist (LABA) combination treatment. Understanding the impact of different treatment options on… read more here.
Keywords: tio group; acting beta; plus laba; group ... See more keywords